Nicotine therapeutic benefits: Difference between revisions

Line 1,458:

===2024: [https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1427314/full The double-edged nature of nicotine: toxicities and therapeutic potentials]===

~~=== 2023: [https://www.frontiersin.org/articles/10.3389/fcvm.2023.1111673/full A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use] ===~~

* The findings of this systematic review and meta-analysis indicate that, with moderate certainty, there are no significant associations between the use of nicotine and the risk of clinically diagnosed adverse cardiovascular events—specifically, arrhythmia, nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death.

=== 2014 [http://journals.cambridge.org/abstract_S1834261214000279 Nicotine: Pharmacology, Toxicity and Therapeutic use] ===

* Karl Fagerström. Journal of Smoking Cessation, 9, pp 53-59 doi:10.1017/jsc.2014.27

* May need a new heading: general therapeutic use

~~===[https://pubmed.ncbi.nlm.nih.gov/?term=Mundel+nicotine Mundel nicotine search - exercise/athletics]===~~

~~===[https://pubmed.ncbi.nlm.nih.gov/?term=Zandonai+nicotine Zandonai nicotine search exercise/athletics]===~~

===2023: [https://drive.google.com/file/d/1ofdbKWq6rIBxI8vQAzjV8z-TYoacrqKB/view Electronic Cigarettes: an Overlooked Tool to Alleviate Disparities in Tobacco Use Disorder Among People with Mental Health and Substance Use Disorders]===

@@ Line 1,458: / Line 1,458: @@
 ===2024: [https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1427314/full The double-edged nature of nicotine: toxicities and therapeutic potentials]===
-=== 2023: [https://www.frontiersin.org/articles/10.3389/fcvm.2023.1111673/full A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use] ===
-* The findings of this systematic review and meta-analysis indicate that, with moderate certainty, there are no significant associations between the use of nicotine and the risk of clinically diagnosed adverse cardiovascular events—specifically, arrhythmia, nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death.
 === 2014 [http://journals.cambridge.org/abstract_S1834261214000279 Nicotine: Pharmacology, Toxicity and Therapeutic use] ===
 * Karl Fagerström. Journal of Smoking Cessation, 9, pp 53-59 doi:10.1017/jsc.2014.27
 * May need a new heading: general therapeutic use
-===[https://pubmed.ncbi.nlm.nih.gov/?term=Mundel+nicotine Mundel nicotine search - exercise/athletics]===
-===[https://pubmed.ncbi.nlm.nih.gov/?term=Zandonai+nicotine Zandonai nicotine search exercise/athletics]===
 ===2023: [https://drive.google.com/file/d/1ofdbKWq6rIBxI8vQAzjV8z-TYoacrqKB/view Electronic Cigarettes: an Overlooked Tool to Alleviate Disparities in Tobacco Use Disorder Among People with Mental Health and Substance Use Disorders]===